![The Combined Contraceptive Vaginal Ring (NuvaRing): Evaluation of the Clinical and Pharmacological Evidence - Christian J Gruber, 2006 The Combined Contraceptive Vaginal Ring (NuvaRing): Evaluation of the Clinical and Pharmacological Evidence - Christian J Gruber, 2006](https://journals.sagepub.com/cms/10.2217/17455057.2.3.351/asset/images/large/10.2217_17455057.2.3.351-fig3.jpeg)
The Combined Contraceptive Vaginal Ring (NuvaRing): Evaluation of the Clinical and Pharmacological Evidence - Christian J Gruber, 2006
Frequently Asked Questions About NuvaRing® (etonogestrel/ethinyl estradiol vaginal ring) Delivers 0.120 mg/0.015 mg Per Day
![Qualitative exploration of intrinsic and extrinsic factors that influence acceptability of semisoft vaginal suppositories | BMC Women's Health | Full Text Qualitative exploration of intrinsic and extrinsic factors that influence acceptability of semisoft vaginal suppositories | BMC Women's Health | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12905-018-0657-2/MediaObjects/12905_2018_657_Fig3_HTML.png)